Literature DB >> 27825853

Nrf2 signaling pathway: Pivotal roles in inflammation.

Syed Minhaj Uddin Ahmed1, Lin Luo2, Akhileshwar Namani1, Xiu Jun Wang3, Xiuwen Tang4.   

Abstract

Inflammation is the most common feature of many chronic diseases and complications, while playing critical roles in carcinogenesis. Several studies have demonstrated that Nrf2 contributes to the anti-inflammatory process by orchestrating the recruitment of inflammatory cells and regulating gene expression through the antioxidant response element (ARE). The Keap1 (Kelch-like ECH-associated protein)/Nrf2 (NF-E2 p45-related factor 2)/ARE signaling pathway mainly regulates anti-inflammatory gene expression and inhibits the progression of inflammation. Therefore, the identification of new Nrf2-dependent anti-inflammatory phytochemicals has become a key point in drug discovery. In this review, we discuss the members of the Keap1/Nrf2/ARE signal pathway and its downstream genes, the effects of this pathway on animal models of inflammatory diseases, and crosstalk with the NF-κB pathway. In addition we also discuss about the regulation of NLRP3 inflammasome by Nrf2. Besides this, we summarize the current scenario of the development of anti-inflammatory phytochemicals and others that mediate the Nrf2/ARE signaling pathway.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ARE; Inflammation; Keap1; Nrf2; Oxidative stress; Phytochemical

Mesh:

Substances:

Year:  2016        PMID: 27825853     DOI: 10.1016/j.bbadis.2016.11.005

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Basis Dis        ISSN: 0925-4439            Impact factor:   5.187


  371 in total

Review 1.  ACOD1 in immunometabolism and disease.

Authors:  Runliu Wu; Feng Chen; Nian Wang; Daolin Tang; Rui Kang
Journal:  Cell Mol Immunol       Date:  2020-06-29       Impact factor: 11.530

2.  Enhancing the Nrf2 Antioxidant Signaling Provides Protection Against Trichloroethene-mediated Inflammation and Autoimmune Response.

Authors:  Nivedita Banerjee; Hui Wang; Gangduo Wang; M Firoze Khan
Journal:  Toxicol Sci       Date:  2020-05-01       Impact factor: 4.849

Review 3.  Inflammation as a mediator of arterial ageing.

Authors:  Daniel W Trott; Paul J Fadel
Journal:  Exp Physiol       Date:  2019-08-08       Impact factor: 2.969

4.  Combating Parkinson's disease-associated toxicity by modulating proteostasis.

Authors:  Yangshin Park; Quyen Q Hoang
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-17       Impact factor: 11.205

5.  Prognosis of hormone-dependent breast cancer seems to be influenced by KEAP1, NRF2 and GSTM1 genetic polymorphisms.

Authors:  Micaela Almeida; Mafalda Soares; Ana Cristina Ramalhinho; José Fonseca Moutinho; Luiza Breitenfeld
Journal:  Mol Biol Rep       Date:  2019-04-02       Impact factor: 2.316

Review 6.  Redox Imbalance in Intestinal Fibrosis: Beware of the TGFβ-1, ROS, and Nrf2 Connection.

Authors:  Giovanni Latella
Journal:  Dig Dis Sci       Date:  2018-02       Impact factor: 3.199

7.  Gedunin Inhibits Oligomeric Aβ1-42-Induced Microglia Activation Via Modulation of Nrf2-NF-κB Signaling.

Authors:  Sara Tom; Anand Rane; Aditya S Katewa; Manish Chamoli; Rae R Matsumoto; Julie K Andersen; Shankar J Chinta
Journal:  Mol Neurobiol       Date:  2019-05-24       Impact factor: 5.590

Review 8.  Food as medicine: targeting the uraemic phenotype in chronic kidney disease.

Authors:  Denise Mafra; Natalia A Borges; Bengt Lindholm; Paul G Shiels; Pieter Evenepoel; Peter Stenvinkel
Journal:  Nat Rev Nephrol       Date:  2020-09-22       Impact factor: 28.314

9.  Synthesis and Evaluation of Noncovalent Naphthalene-Based KEAP1-NRF2 Inhibitors.

Authors:  Phillip R Lazzara; Atul D Jain; Amanda C Maldonado; Benjamin Richardson; Kornelia J Skowron; Brian P David; Zamia Siddiqui; Kiira M Ratia; Terry W Moore
Journal:  ACS Med Chem Lett       Date:  2020-02-19       Impact factor: 4.345

Review 10.  Common and Novel Markers for Measuring Inflammation and Oxidative Stress Ex Vivo in Research and Clinical Practice-Which to Use Regarding Disease Outcomes?

Authors:  Alain Menzel; Hanen Samouda; Francois Dohet; Suva Loap; Mohammed S Ellulu; Torsten Bohn
Journal:  Antioxidants (Basel)       Date:  2021-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.